Funds · BBOT

Who owns BBOT?

Institutional ownership of BridgeBio Oncology Therapeutics Inc. from Form 13F, Q2 2026

66 institutional managers reported holding BridgeBio Oncology Therapeutics Inc. (BBOT) in Form 13F filings for Q2 2026, with 59,128,852 shares worth $451M. The largest reported holder was Cormorant Asset Management, LP. Managers that filed both quarters added a net 1,649,811 shares (+2.9%). 17 opened new positions and 18 sold out.

Funds holding
66
Value held
$451M
New / sold out
17 / 18
Net shares, same filers
+2.9%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of BBOT

FundValueShare of 13F holdingsSharesMove
Cormorant Asset Management, LP$136M30.2%17,878,594Unchanged
Deerfield Management Company, L.p.$37.2M8.3%4,885,446Unchanged
Omega Fund Management, LLC$25.1M5.6%3,289,661Unchanged
Alphabet Inc.$21.5M4.8%2,823,126Unchanged
EcoR1 Capital, LLC$21.5M4.8%2,823,126Unchanged
Wellington Management Group LLP$21.3M4.7%2,789,302Trimmed
Enavate Sciences GP, LLC$20.0M4.4%2,626,946Unchanged
Citadel Advisors LLC$19.9M4.4%2,617,827Added
Novo Holdings A/S$17.1M3.8%2,250,000Added
BlackRock, Inc.$16.4M3.6%2,154,040Added
Vanguard Capital Management LLC$15.3M3.4%2,005,649Added
Laurion Capital Management LP$15.3M3.4%2,002,701Added
Armistice Capital, LLC$13.4M3.0%1,764,000Added
State Street Corp$7.9M1.8%1,036,569Added
Aisling Capital Management LP$7.8M1.7%1,018,018Unchanged
Opaleye Management Inc.$5.3M1.2%700,000Added
Geode Capital Management, LLC$4.7M1.1%622,351Added
Granahan Investment Management, LLC$4.3M0.9%558,526Added
Sphera Funds Management LTD.$3.5M0.8%460,985New
Adage Capital Partners GP, L.l.c.$3.0M0.7%400,000Unchanged
Royce & Associates LP$2.9M0.7%384,941Trimmed
Catalio Capital Management, LP$2.4M0.5%318,407New
Price T Rowe Associates Inc$2.3M0.5%300,000Trimmed
Vanguard Fiduciary Trust Co$2.2M0.5%291,522Added
Charles Schwab Investment Management Inc$2.2M0.5%286,518Trimmed

Share of 13F holdings is each fund's shares as a share of the 59,128,852 BBOT shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $42.4M and sold $33.7M; 21 added and 15 trimmed.

Schedule 13D and 13G filings on BBOT

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about BBOT ownership

Who owns BBOT stock?
66 institutional investment managers reported BBOT positions in their Form 13F filings for Q2 2026, holding 59,128,852 shares worth $451M in total. Cormorant Asset Management, LP reported the largest position.
Are funds buying or selling BBOT?
In Q2 2026, 17 managers opened new BBOT positions, 21 added, 15 trimmed and 18 sold out. Managers that filed in both quarters added a net 1,649,811 shares.
How current is this BBOT institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BBOT by CUSIP. Options are left out. BBOT news and filings · BBOT insider trades · Top funds